InvestorsHub Logo
Followers 118
Posts 7889
Boards Moderated 0
Alias Born 09/02/2011

Re: Kingsolomonspoolz post# 13797

Tuesday, 03/07/2017 11:44:50 AM

Tuesday, March 07, 2017 11:44:50 AM

Post# of 74755
The company is releasing a PR soon, everyone has heard that!

This is the focus now...

REPOST

https://www.drugs.com/otc/129916/tetrastem.html
(licensed as Diabecline and Viabecline). Regardless of who owns or has the rights to the patent, ViaDerma has licensing rights, and has filed a new patent pending application for the transdermal system.

That is HUGE!!!!!!

And sales coming from the licensing rights!
http://www.marketwatch.com/story/viaderma-inc-targets-online-sales-wound-care-centers-and-distribution-companies-for-its-viabecline-product-launch-the-first-viabecline-orders-set-for-q2-2017-also-onychomycosis-clinical-studies-show-significant-results-2017-02-03

REPOST...

This is our GOLDEN ticket! The focus should be on the patent pending transdermal system that can deliver medications and nutrients into the body through the skin.

http://www.marketwatch.com/story/viaderma-inc-looks-to-file-additional-patents-license-new-products-for-its-mmj-medical-marijuana-patent-pending-delivery-technology-with-licensed-dispensaries-2017-02-15

$VDRM is GOLDEN
Next run is to .10-.12+ this month!
Awaiting the next BIG PR!!